Medicis Pharmaceutical Corporation (MRX)
22.34USD
9 Feb 2010
$0.08 (+0.36%)
$22.34
--
$22.54
$21.94
765,109
1,046,303
$28.10
$7.85
MRX
About
Overall
| Beta: | 1.50 |
| Market Cap (Mil.): | $1,328.89 |
| Shares Outstanding (Mil.): | 59.48 |
| Annual Dividend: | 0.16 |
| Yield (%): | 0.72 |
Financials
| MRX | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 49.72 | 1.96 | 3.76 |
| EPS (TTM): | -33.81 | -- | -- |
| ROI: | 3.52 | 0.92 | 2.30 |
| ROE: | 4.36 | 1.27 | 2.82 |
Senate health bill alters company taxes, profits
WASHINGTON (Reuters) - Proposed changes to the Senate's pending healthcare reform bill include measures targeting industry profits and taxes, and a move to ensure health insurers spend a certain amount on medical care, according to a document released on Saturday.
Senate health bill alters company taxes, profits
WASHINGTON (Reuters) - Proposed changes to the Senate's pending healthcare reform bill include measures targeting industry profits and taxes, and a move to ensure health insurers spend a certain amount on medical care, according to a document released on Saturday.
UPDATE 2-US Senate health bill alters company taxes, profits
* No "Botax," tanning taxes to raise $2.7 billion (Adds industry reaction, paragraph 11, background)
Senate health bill alters company taxes, profits
WASHINGTON (Reuters) - Proposed changes to the U.S. Senate's pending healthcare reform bill include measures targeting industry profits and taxes, and a move to ensure health insurers spend a certain amount on medical care, according to a document released on Saturday.
UPDATE 1-US Senate health bill alters company taxes, profits
* No "Botax," tanning taxes to raise $2.7 billion (Adds details from amendments, industry reaction, background)
US Senate health bill alters company taxes, profits
WASHINGTON, Dec 19 (Reuters) - Proposed changes to the Senate's pending healthcare reform bill include a number of revisions targeting industry profits and taxes, including a move to ensure health insurers spent a certain amount of money on medical care, according to a document released on Saturday.
Senate nears first healthcare vote
WASHINGTON (Reuters) - Democrats in the U.S. Senate geared up for a fierce battle over a new healthcare reform plan on Thursday as Republicans condemned the bill's price tag and tax hikes before the first crucial test vote on Saturday. | Video
WRAPUP 3-U.S. Senate nears first healthcare vote
(For full coverage of the healthcare debate [nN20512341])
Competitors
| Price | Change | |
|---|---|---|
| Allergan, Inc. (AGN.N) | $58.75 | +0.58 |
| Johnson & Johnson (JNJ.N) | $62.76 | +0.39 |
| Sanofi-Aventis SA (SASY.PA) | €52.95 | +0.29 |
| Warner Chilcott Plc (WCRX.OQ) | $25.51 | +0.30 |
| Bristol Myers Squibb Co. (BMY.N) | $24.25 | +0.29 |
| Bristol Myers Squibb Co. (BMY_p.N) | $439.50 | 0.00 |
| GlaxoSmithKline plc (GSK.L) | £1,203.50 | -15.00 |
| Pfizer Inc. (PFE.N) | $17.88 | +0.04 |
| Schering-Plough Corporation (SGP.N) | -- | -- |
| Valeant Pharmaceuticals International (VRX.N) | $35.55 | +1.06 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
